Automate Your Wheel Strategy on LUNG
With Tiblio's Option Bot, you can configure your own wheel strategy including LUNG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LUNG
- Rev/Share 2.2528
- Book/Share 1.7189
- PB 0.9628
- Debt/Equity 0.8225
- CurrentRatio 5.3468
- ROIC -0.4658
- MktCap 67435623.0
- FreeCF/Share -0.7956
- PFCF -2.1087
- PE -1.1683
- Debt/Assets 0.3861
- DivYield 0
- ROE -0.6976
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | LUNG | Piper Sandler | Overweight | Neutral | -- | $2.5 | July 31, 2025 |
| Initiation | LUNG | D. Boral Capital | -- | Buy | -- | $17 | March 10, 2025 |
| Downgrade | LUNG | Citigroup | Buy | Neutral | $17 | $7.5 | Dec. 11, 2024 |
News
What Makes Pulmonx (LUNG) a New Buy Stock
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Pulmonx (LUNG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Negative
Pulmonx (LUNG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read More
Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript
Published: February 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Pulmonx Corporation (NASDAQ:LUNG ) Q4 2024 Results Conference Call February 19, 2025 4:30 PM ET Company Participants Elizabeth Sparicio - Investor Relations Steve Williamson - President and Chief Executive Officer Mehul Joshi - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Jon Young - Canaccord Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Joseph Downing - Piper Sandler Operator Ladies and gentlemen, thank you for standing by. Welcome to Pulmonx Fourth Quarter 2024 Earnings Conference Call.
Read More
About Pulmonx Corporation (LUNG)
- IPO Date 2020-10-01
- Website https://pulmonx.com
- Industry Medical - Devices
- CEO Steven S. Williamson
- Employees 291